Clinical and neurobiological correlates of D10S1423 genotype in Alzheimer's disease

Biological Psychiatry

Volumn 46, Issue 6, 1999, Pages 740-749

  Zubenko, George S ^a,b   Hughes III, Hugh B ^a   Stiffler, J Scott ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b Mellon Coll Sci Carnegie M   (United States)

Author keywords

Alzheimer's disease; Clinical and neurobiological correlates; Genetic phenotypic heterogeneity; Genetics

Indexed keywords

NORADRENALIN;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; FEMALE; GENE LOCUS; GENETIC PREDISPOSITION; GENOTYPE; HUMAN; HUMAN TISSUE; MALE; NORADRENALIN BRAIN LEVEL; PRIORITY JOURNAL;

AGED; ALLELES; ALZHEIMER DISEASE; BRAIN; CULTURE TECHNIQUES; DOPAMINE; FEMALE; GENE EXPRESSION; GENES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MICROSATELLITE REPEATS; POLYMERASE CHAIN REACTION;

EID: 0032842185     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(99)00021-9     Document Type: Article

References (96)

1. Alafuzoff I., Iqbal K., Friden H., Adolfsson R., Winblad B. Histopathological criteria for progressive dementia disorders clinical-pathological correlation and classification by multivariate data analysis . Acta Neuropathol. 74:1987;209-225.
2. The structure of the presenilin 1 (S182) gene and identification of six novel mutations in early onset AD families. Nature Genet. 11:1995;219-222.
3. Bachman D.L., Wolf P.A., Linn R., Konefel J.E., Cobb J., Belanger A., et al. Prevalence of dementia and probable senile dementia of the Alzheimer type in the Framingham Study. Neurology. 42:1992;115-119.
4. Bendotti C., Forloni G., Morgan R., O'Hara B.F., Oster-Granite L., Reeves R.H., et al. Neuroanatomical localization and quantification of amyloid precursor protein mRNA by in situ hybridization in the brains of normal, aneuploid and lesioned mice. Proc Natl Acad Sci USA. 85:1988;3628-3632.
5. Blacker D., Wilcox M.A., Laird N.M., Rodes L., Horvath S.M., Go R.C.P., et al. Alpha-2-macroglobulin is genetically associated with Alzheimer's disease. Nature Genet. 119:1998;357-360.
6. Boller F., Lopez O.L., Moossy J. Diagnosis of dementia clinicopathologic correlations . Neurology. 39:1989;76-79.
7. Brion S., Plas J., Jeanneau A. La maladie de Pick. Point de vue anatomo-clinique. Rev Neurol. 147:1991;693-704.
8. Campion D., Flaman J.-M., Brice A., Hennequin D., Dubois B., Martin C., et al. Mutations of the presenilin 1 gene in families with early-onset Alzheimer's disease. Hum Mol Genet. 4:1995;2373-2377.
9. Chakravarti A., Slaugenhaupt S., Zubenko G.S. Inheritance pattern of platelet membrane fluidity in Alzheimer's disease. Am J Hum Genet. 44:1989;799-805.
10. Chan-Palay V. Depression and senile dementia of the Alzheimer type catecholamine changes in the locus coeruleus - basis for therapy . Dementia. 1:1990;253-261.
11. Chartier-Harlin M.-C., Crawford F., Houlden H., Warren A., Hughes D., Fidani L., et al. Early-onset Alzheimer's disease caused by mutations at codon 717 of the β-amyloid precursor protein gene. Nature. 353:1991;844-846.
12. Chartier-Harlin M.-C., Parfitt M., Legrain S., Perez-Tur J., Brousseau T., Evans A., et al. Apolipoprotein E, ε4 allele as a major risk factor for sporadic early and late-onset forms of Alzheimer's disease analysis of the 19q13.2 chromosomal region . Hum Mol Genet. 3:1994;569-574.
13. Chen X., Xia Y., Alford M., DeTeresa R., Hansen L., Klauber M.R., et al. The CYP2D6B allele is associated with a milder synaptic pathology in Alzheimer's disease. Ann Neurol. 38:1995;653-658.
14. Corder E.H., Saunders A.M., Risch N.J., Strittmatter W.J., Schmechel D.E., Gaskell P.C. Jr, et al. Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer's disease. Nature Genet. 7:1994;180-184.
15. Corder E.H., Saunders A.M., Strittmatter W.J., Schmechel D.E., Gaskell P.C., Small G.W., et al. Gene dose of apolipoprotein E type-4 allele and the risk of Alzheimer's disease in late onset families. Science. 261:1993;921-923.
16. Cruts M., Backhovens H., Wang Y., Gassen G.V., Theuns J., DeJonghe C., et al. Molecular genetic analysis of familial early-onset Alzheimer's disease linked to chromosome 14q24.3. Hum Mol Genet. 4:1995;2363-2371.
17. Dai X.Y., Nanko S., Hattori M., Fukuda R., Nagata K., Isse K., et al. Association of apolipoprotein E4 with sporadic Alzheimer's disease is more pronounced in early onset type. Neurosci Lett. 175:1994;74-76.
18. Daniel S.E., Lees A.J. Parkinson's Disease Society Brain Bank, London overview and research . J Neural Transm. 39:1993;165-172.
19. Davis R.E., Miller S., Herrnstadt C., Ghosh S.S., Fahy E., Shinobu L.A., et al. Mutations in mitochondrial cytochrome c oxidase genes segregate with late-onset Alzheimer disease. Proc Natl Acad Sci USA. 94:1997;4526-4531.
20. Dickson D.W., Crystal H., Mattiace L.A., Kress Y., Schwagerl A., Ksiezak-Reding H., et al. Diffuse Lewy body disease light and electron microscopic immunocytochemistry of senile plaques . Acta Neuropathol. 78:1989;572-584.
21. Ditter S.M., Mirra S.S. Neuropathologic and clinical features of Parkinson's disease in Alzheimer's disease patients. Neurology. 37:1987;754-760.
22. Evans D.A., Funkenstein H.H., Albert M.S., Scherr P.A., Cook N.R., Chown M.J., et al. Prevalence of Alzheimer's disease in a community population of older persons higher than previously reported . JAMA. 262:1989;2551-2556.
23. Faraone S.V., Matise T., Svrakic D., Pepple J., Malaspina D., Suarez B., et al. Genome scan of European American schizophrenia pedigrees Results of the NIMH Genetics Initiative and Millenium Consortium . Am J Med Genet (Neuropsychiatr Genet). 81:1998;290-295.
24. Fonnum F. Radiochemical microassays for the determination of choline acetyltransferase and acetylcholinesterase activity. Biochem J. 115:1969;465-472.
25. Förstl H., Burns A., Levy R., Cairns N., Luthert P., Lantos P. Neurologic signs in Alzheimer's disease. Results of a prospective clinical and neuropathologic study. Arch Neurol. 49:1992;1038-1042.
26. Förstl H., Burns A., Luthert P., Cairns N., Levy R. The Lewy-body variant of Alzheimer's disease clinical and pathological findings . Brit J Psych. 162:1993;385-392.
27. ™ Human Genome Database [database on-line]. Baltimore (Maryland, USA): Johns Hopkins University, 1990. Updated daily. Available from Internet: URL http://www.gdb.org/ [cited 4 Sept 1998a; GDB node: USA, http://www.gdb.org/] Mapview display of GDB maps: GDB Comprehensive Map - Chr. 10.
28. ™ Human Genome Database [database online]. Baltimore (Maryland, USA): Johns Hopkins University, 1990. Updated daily. Available from Internet: URL http://www.gdb.org/ [cited 16 Sept 1998b; GDB node: USA, http://www.gdb.org/] GDB Data Type: Amplimer; Object name: CHLC.GATA70E11.P18111; GDB: 685545.
29. Goate A.M., Chartier-Harlin M.-C., Mullan M., Brown J., Crawford F., Fidani L., et al. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature. 349:1991;704-706.
30. Hansen L., Salmon D., Galasko D., Masliah E., Katzman R., DeTeresa R., et al. The Lewy body variant of Alzheimer's disease a clinical and pathologic entity . Neurology. 40:1990;1-8.
31. Hendrie H.C., Hall K.S., Hui S., Unverzagt F.W., Yu C.E., Lahiri D.K., et al. Apolipoprotein E genotypes and Alzheimer's disease in a community study of elderly African Americans. Ann Neurol. 37:1995;118-120.
32. Hixson J.E., Vernier D.T. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res. 31:1990;545-548.
33. Holland A.J. Down's syndrome and dementia of the Alzheimer type. Burns A., Levy R. Dementia. 1994;695-708 Chapman and Hall, London.
34. Holmes C., Russ C., Kirov G., Aitchison K.J., Powell J.F., Collier D.A., Lovestone S. Apolipoprotein E Depressive illness, depressive symptoms, and Alzheimer's disease . Biol Psychiatry. 43:1998;159-164.
35. Joachim C.L., Morris J.H., Selkoe D.J. Clinically diagnosed Alzheimer's disease autopsy results in 150 cases . Ann Neurol. 24:1988;50-56.
36. Jorm A.F., Korten A.E., Henderson A.S. The prevalence of dementia a quantitative integration of the literature . Acta Psychiatr Scand. 76:1987;465-479.
37. Khachaturian Z.S. Diagnosis of Alzheimer's disease. Arch Neurol. 42:1985;1097-1105.
38. Kimura S., Umeno M., Skoda R.C., Meyer U.A., Gonzalez F.J. The human debrisoquine 4-hydroxlyase (CYP2D) locus sequence and identification of the polymorphic CYP2D6 gene, a related gene, and a pseudogene . Am J Hum Genet. 45:1989;889-904.
39. Langlais P.J., Thal L., Hansen L., Galasko D., Alford M., Masliah E. Neurotransmitters in basal ganglia and cortex of Alzheimer's disease with and without Lewy bodies. Neurol. 43:1993;1927-1934.
40. Leverenz J., Sumi S.M. Parkinson's disease in patients with Alzheimer's disease. Arch Neurol. 43:1986;662-664.
41. Levy-Lahad E., Wasco W., Poorkaj P., Romano D.M., Oshima J., Pettingell W.H., et al. Candidate gene for the chromosome 1 familial Alzheimer's disease locus. Science. 269:1995;973-977.
42. Levy-Lahad E., Wijsman E.M., Nemens E., Anderson L., Goddard K.A.B., Weber J.L., et al. A familial Alzheimer's disease locus on chromosome 1. Science. 269:1995;970-973.
43. Lippa C.F., Smith T.W., Swearer J.M. Alzheimer's disease and Lewy body disease a comparative clinicopathological study . Ann Neurol. 35:1994;81-88.
44. Maestre G., Ottman R., Stern Y., Gurland B., Chun M., Tang M.X., et al. Apolipoprotein E and Alzheimer's disease ethnic variation in genotypic risks . Ann Neurol. 37:1995;254-259.
45. McKeith I.G., Perry R.H., Fairbairn A.F., Jabeen S., Perry E.K. Operational criteria for senile dementia of Lewy body type (SDLT). Psychol Med. 22:1992;911-922.
46. Mendez M.F., Mastri A.R., Sung J.H., Frey W.H. Clinically diagnosed Alzheimer's disease neuropathologic findings in 650 cases . Alzheimer Dis Assoc Disord. 6:1992;35-43.
47. Mirra S.S., Heyman A., McKeel D., Sumi S.M., Crain C.J., Brownlee L.M., et al. The consortium to establish a registry for Alzheimer's disease (CERAD). Neurology. 41:1991;479-486.
48. Moossy J., Zubenko G.S., Martinez A.J., Rao G.R. Bilateral symmetry of morphologic lesions in Alzheimer's disease. Arch Neurol. 45:1988;251-254.
49. Morris J.C., McKeel D.W., Fulling K., Torack R.M., Berg L. Validation of clinical diagnostic criteria for Alzheimer's disease. Ann Neurol. 24:1988;17-22.
50. Mullan M., Crawford F., Axelman K., Houlden H., Lulius L., Winblad B., et al. A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N-terminus of β-amyloid. Nature Genet. 1:1992;345-347.
51. Murrell J., Farlow M., Ghetti B., Benson M.D. A mutation in the amyloid precursor protein associated with hereditary Alzheimer's disease. Science. 254:1991;97-99.
52. Myklebost O., Rogne S. A physical map of the apolipoprotein gene cluster on human chromosome 19. Hum Genet. 78:1988;244-247.
53. Nechiporuk A., Fain P., Kort E., Nee L.E., Frommelt E., Polinsky R.J., et al. Linkage of familial Alzheimer disease to chromosome 14 in 2 large early-onset pedigrees effects of marker allele frequencies on LOD scores . Am J Med Genet. 48:1993;63-66.
54. Okuizumi K., Onodera O., Tanaka H., Kobayashi H., Tsuji S., Takahashi H., et al. ApoE-epsilon 4 and early-onset Alzheimer's. Nature Genet. 7:1994;10-11.
55. th ed. 1992;991-997 Oxford University Press, New York.
56. Pericak-Vance M.A., Bass M.P., Yamaoka L.H., Gaskell P.C., Scott W.K., Terwedow H.A., et al. Complete genomic screen in late-onset familial Alzheimer disease. Evidence for a new locus on chromosome 12. JAMA. 278:1997;1237-1241.
57. Perry E.K., Haroutunian V., Davis K.L., Levy R., Lantos P., Eagger S., et al. Neocortical cholinergic activities differentiate Lewy body dementia from classical Alzheimer's disease. NeuroReport. 5:1994;747-749.
58. Perry E.K., Marshall E., Perry R.H., Irving D., Smith C.J., Blessed G., et al. Cholinergic and dopaminergic activities in senile dementia of Lewy body type. Alz Dis Assoc Disord. 4:1990;87-95.
59. Rebeck G.W., Reiter J.S., Strickland D.K., Hyman B.T. Apolipoprotein E in sporadic Alzheimer's disease allelic variation and receptor interactions . Neuron. 11:1993;575-580.
60. Rogaev E.I., Sherrington R., Rogaeva E.A., Levesque G., Ikeda M., Liang Y., et al. Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene. Nature. 376:1995;775-778.
61. Rumble B., Retallack R., Hilbich C., Simms G., Multhaup G., Martins R., et al. Amyloid A4 protein and its precursor in Down's syndrome and Alzheimer's disease. N Engl J Med. 320:1989;1446-1452.
62. Sahara N., Yahagi Y.-I., Takagi H., Kondo T., Okochi M., Susami M., et al. Identification and characterization of presenilin I-467, I-463, and I-374. FEBS Lett. 381:1996;7-11.
63. Saitoh T., Xia Y., Chen X., Masliah E., Glaasko D., Shults C., et al. The CYP2D6B mutant allele is overrepresented in the Lewy body variant of Alzheimer's disease. Ann Neurol. 37:1995;110-112.
64. Saller C.F., Salama A.I. Rapid automated analysis of biogenic amines and their metabolites using reversed-phase high performance liquid chromatography with electrochemical detections. J Chromatogr. 309:1984;287-298.
65. Saunders A.M., Strittmatter W.J., Schmechel D., St. George-Hyslop P.H., Pericak-Vance M.A., Joo S.H., et al. Association of apolipoprotein E allele ε4 with late-onset familial and sporadic Alzheimer's disease. Neurology. 43:1993;1467-1472.
66. Schellenberg G.D., Bird T.D., Wijsman E.M., Orr H.T., Anderson L., Nemens E., et al. Genetic linkage evidence for a familial Alzheimer's disease locus on chromosome 14. Science. 258:1992;668-671.
67. Schmechel D., Saunders A., Strittmatter W., Crain B.J., Hulette C.M., Joo S.H., et al. Increased amyloid β-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease. Proc Natl Acad Sci USA. 90:1993;9649-9653.
68. Sherrington R., Govaev E.I., Liang Y., Rogaeva E.A., Levesque G., Ikdea M., et al. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature. 375:1995;754-760.
69. Smith C.A.D., Gough A.C., Leigh P.N., Summers B.A., Harding A.E., Maranganore D.M., et al. Debrisoquine hydroxylase gene polymorphism and susceptibility to Parkinson's disease. Lancet. 339:1992;1375-1377.
70. Spatz H (1952): La maladie de Pick, les atrophies systématisées progressives et la sénescence cérébrale prématurée localisce. In: The Proceeding of the First International Congress of Neuropathology, vol. 2. Torino: Rosenberg, Sellier, pp 375-406.
71. St. George-Hyslop P., Haines J., Rogaev E., Mortilla M., Vaula G., Pericak-Vance M., et al. Genetic evidence for a novel familial Alzheimer's disease locus on chromosome 14. Nature Genet. 2:1992;330-334.
72. Strittmatter W.J., Saunders A.M., Schmechel D., Pericak-Vance M., Enghild J., Salvesen G.S., et al. Apolipoprotein E high-avidity binding to β-amyloid and increased frequency of type 4 allele in late onset familial Alzheimer disease . Proc Natl Acad Sci USA. 90:1993;1977-1981.
73. Tissot R., Constantinidis J., Richard J. La Maladie de Pick. 1975;1-222 Masson, Paris.
74. Ueki A., Kawano M., Namba Y., Kawakami M., Ikeda K. A high frequency of apolipoprotein E4 isoprotein in Japanese patients with late-onset nonfamilial Alzheimer's disease. Neurosci Lett. 163:1993;166-168.
75. van Broeckhoven C., Backhovens H., Cruts M., de Winter G., Bruyland M., Cras P., et al. Mapping of a gene predisposing to early-onset Alzheimer's disease to chromosome 14q24.3. Nature Genet. 2:1992;335-339.
76. van Duijn C.M., de Knijff P., Cruts M., Wehner A., Havekes L.M., Hofman A., et al. Apolipoprotein E4 allele in a population-based study of early-onset Alzheimer's disease. Nature Genet. 7:1994;74-78.
77. Victoroff J., Mack W.J., Lyness S.A., Chiu H.C. Multicenter clinicopathological correlation in dementia. Am J Psychiatry. 152:1995;1476-1484.
78. Wade J.P.H., Mirsen T.R., Hachinski V.C., Fisman M., Lau C., Merskey H. The clinical diagnosis of Alzheimer's disease. Arch Neurol. 44:1987;24-29.
79. Weiner M.F., Risser R.C., Cullum C.M., Honig L., White C., Speciale S., et al. Alzheimer's disease and its Lewy body variant a clinical analysis of postmortem verified cases . Am J Psychiatry. 153:1996;1269-1273.
80. Yoshizawa T., Yamakawkobayashi K., Komatsuzaki Y., Arinami T., Oguni E., Mizusawa H., et al. Dose-dependent association of apolipoprotein E allele epsilon 4 with late-onset, sporadic Alzheimer's disease. Ann Neurol. 36:1994;656-659.
81. Zubenko G.S. Hippocampal membrane alteration in Alzheimer's disease. Brain Res. 385:1986;115-121.
82. Zubenko G.S. Clinicopathological and neurochemical correlates of major depression and psychosis in primary dementia (in the IPA-sponsored Proceedings of the Consensus Conference on Behavioral Disturbances of Dementia). Int Psychogeriatrics. 8:1996;219-223.
83. Zubenko G.S. Molecular neurobiology of Alzheimer's disease (syndrome?). Harvard Rev Psychiatry. 5:1997;177-213.
84. Zubenko G.S., Cohen B.M., Reynolds C.F., Boller F., Malinakova I., Keefe N. Platelet membrane fluidity in Alzheimer's disease and major depression. Am J Psychiatry. 144:1987;860-868.
85. Zubenko G.S., Henderson R., Stiffler J.S., Stabler S., Rosen J., Kaplan B. Association of APOE ε4 allele with clinical subtypes of late life depression. Biol Psychiatry. 40:1996;1008-1016.
86. Zubenko G.S., Hughes H.B., Stiffler J.S., Hurtt M.R., Kaplan B.B. A genome survey for novel Alzheimer disease risk loci results at 10-cM resolution . Genomics. 50:1998;121-128.
87. Zubenko G.S., Moossy J. Major depression in primary dementia clinical and neuropathologic correlates . Arch Neurol. 45:1988;1182-1186.
88. Zubenko G.S., Moossy J., Hanin I., Martinez A.J., Rao G.R., Kopp U. Bilateral symmetry of cholinergic deficits in Alzheimer's disease. Arch Neurol. 45:1988;255-259.
89. Zubenko G.S., Moossy J., Kopp U. Neurochemical correlates of major depression in primary dementia. Arch Neurol. 47:1990;209-214.
90. Zubenko G.S., Moossy J., Martinez A.J., Rao G.R., Kopp U., Hanin I. A brain regional analysis of morphologic and cholinergic abnormalities in Alzheimer's disease. Arch Neurol. 46:1989;634-638.
91. Zubenko G.S., Stiffler J.S., Hughes H.B., Hurtt M.R., Kaplan B.B. Initial results of a genome survey for novel Alzheimer's disease risk genes Association with a locus on the X chromosome . Am J Med Genet. 81:1998;98-107.
92. Zubenko G.S., Stiffler S., Farr J., Kopp U., Hughes H., Kaplan B.B., Moossy J. Lack of variation in the nucleotide sequence corresponding to the transmembrane domain of the β-amyloid precursor protein in Alzheimer's disease. Am J Med Genet. 48:1993;131-136.
93. Zubenko G.S., Stiffler S., Stabler S., Kopp U., Hughes H.B., Cohen B.M., et al. Association of the apolipoprotein E ε4 allele with clinical subtypes of autopsy-confirmed Alzheimer's disease. Am J Med Genet. 54:1994;199-205.
94. Zubenko G.S., Winwood E., Jacobs B., Teply I., Stiffler J.S., Hughes H.B., et al. Prospective study of risk factors for Alzheimer's disease results at 7.5 years . Am J Psychiatry. 156:1999;50-57.
95. Zubenko G.S., Wusylko M., Boller F., Cohen B.M., Teply I. Family study of platelet membrane fluidity in Alzheimer's disease. Science. 238:1987;539-542.
96. Zweig R.M., Ross C.A., Hedreen J.C., Steele C., Cardiollo J.E., Whitehouse P.J., et al. The neuropathology of aminergic nuclei in Alzheimer's disease. Ann Neurol. 24:1988;233-242.